insights_auto
Why is ALTME down ၄.၅၀%?
Dive Deeperchevron_right
ALTME:EPA
TME Pharma NV
၀.၁၁ €
arrow_downward
-၄.၅၀%(-၀.၀၀၅၀) 1D
အောက် ၂၀, GMT+၂ ၁၇:၃၅:၁၃ · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ALTME...
Open
၀.၁၁ €
High
၀.၁၁ €
Low
၀.၁၀ €
Mkt. cap
၉.၉၇ သန်း
Avg. vol.
၁.၈၅ သန်း
Volume
၁.၉၉ သိန်း
52-wk high
၀.၁၇ €
52-wk low
၀.၀၅ €
EPS
-၀.၀၃ €
No. of employees
၀
Open
၀.၁၁ €
High
၀.၁၁ €
Low
၀.၁၀ €
Mkt. cap
၉.၉၇ သန်း
Avg. vol.
၁.၈၅ သန်း
Volume
၁.၉၉ သိန်း
52-wk high
၀.၁၇ €
52-wk low
၀.၀၅ €
EPS
-၀.၀၃ €
No. of employees
၀
News stories
From web sources and news partners
GlobeNewswire
·
ပြီးခဲ့သည့် ၁ နာရီ
SEGG Media Requests Nasdaq Hearing and Stay Following Staff Determination
BigGo Finance
·
ပြီးခဲ့သည့် ၂၉ မိနစ်
Dow Jumps 530 Points as Health Care Surges to Record; Nasdaq Stalls on AI Spending Worries
MarketBeat
·
ပြီးခဲ့သည့် ၁ နာရီ
Fermi (NASDAQ:FRMI) Shares Down 2.6% - Time to Sell?
Investor's Business Daily
·
ပြီးခဲ့သည့် ၁ နာရီ
Futures Rise On SpaceX Earnings; Tesla, Meta Due
Profile
TME Pharma, formerly NOXXON Pharma, is a biotechnology company founded in 1997 in Berlin, Germany which specialises on cancer treatment by targeting the tumor microenvironment. TME Pharma N.V. is listed on Euronext Growth, Paris and is a member of the German Association of Research-Based Pharmaceutical Companies, Verband forschender Arzneimittelhersteller.
TME Pharma develops drugs using technology yielding L-RNA molecules, which are of mirror-image configuration compared to naturally occurring D-RNA molecules. The company calls these agents Spiegelmers, from Spiegel, the German word for "mirror."
The L-RNA are resistant to the natural RNA nuclease enzymes. Wikipedia
About TME Pharma NV